The biggest stories of the day delivered to your inbox.

who gathered on Wednesday outside the office of Senator Ron Johnson (R-Wis.) in Oshkosh. At 11:30 a.m. on Wednesday, the groups brought signs to display outside Sen. Johnson’s office to rally ...

90 mg once-daily palazestrant dose selected for Part 2 of the Phase 3 OPERA-01 monotherapy trial and for the Phase 3 OPERA-02 combination trial with ribociclib OPERA-01 trial-in-progress poster to be ...

May 22, 2025 /PRNewswire/ -- Accent Therapeutics, a clinical-stage biopharmaceutical company pioneering novel, targeted, small molecule cancer therapeutics, today announced that a Trial in Progress ...

Presenter: Eunice S. Wang, M.D. A post-hoc analysis of the pivotal cohort from the Phase 1/2 study evaluated outcomes in patients with R/R mIDH1 AML who received olutasidenib after either 1-2 or ≥3 ...

He has extensive experience in missile defense and space operations. The Congressional Budget Office estimates that components of the system may incur costs upwards of $831 billion over the next two ...

At the same time, 5,000 square feet opened up on the floor below Foundations’ existing space — which will now be a co-working office for Foundations members and their companies.